MedKoo Cat#: 563075 | Name: MDK-4683

Description:

WARNING: This product is for research use only, not for human or veterinary use.

MDK-4683, also known as CA IX/XII Inhibitor, is an inhibitor of hCA IX and hCA XII. MDK-4683 has CAS#175014-68-3, has no formal name. For the convenience of scientific communication, we name this chemical as MDK-4683. The last four digit of its CAS# was used for name.

Chemical Structure

MDK-4683
MDK-4683
CAS#175014-68-3

Theoretical Analysis

MedKoo Cat#: 563075

Name: MDK-4683

CAS#: 175014-68-3

Chemical Formula: C13H12N4O5S

Exact Mass: 336.0528

Molecular Weight: 336.32

Elemental Analysis: C, 46.43; H, 3.60; N, 16.66; O, 23.79; S, 9.53

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
CA IX/XII Inhibitor; MDK-4683; MDK4683; MDK 4683;
IUPAC/Chemical Name
4-Nitro-4'-sulfamyl-carbanilide
InChi Key
UUZKJPOBWQCXEM-UHFFFAOYSA-N
InChi Code
InChI=1S/C13H12N4O5S/c14-23(21,22)12-7-3-10(4-8-12)16-13(18)15-9-1-5-11(6-2-9)17(19)20/h1-8H,(H2,14,21,22)(H2,15,16,18)
SMILES Code
O=C(NC1=CC=C(S(=O)(N)=O)C=C1)NC2=CC=C([N+]([O-])=O)C=C2
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 336.32 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Pustenko A, Stepanovs D, Žalubovskis R, Vullo D, Kazaks A, Leitans J, Tars K, Supuran CT. 3H-1,2-benzoxathiepine 2,2-dioxides: a new class of isoform-selective carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem. 2017 Dec;32(1):767-775. doi: 10.1080/14756366.2017.1316720. PubMed PMID: 28537099. 2: Carta F, Vullo D, Osman SM, AlOthman Z, Supuran CT. Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs. Bioorg Med Chem. 2017 May 1;25(9):2569-2576. doi: 10.1016/j.bmc.2017.03.027. Epub 2017 Mar 18. PubMed PMID: 28347633. 3: Nocentini A, Carta F, Ceruso M, Bartolucci G, Supuran CT. Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII. Bioorg Med Chem. 2015 Nov 1;23(21):6955-66. doi: 10.1016/j.bmc.2015.09.041. Epub 2015 Sep 28. PubMed PMID: 26432607. 4: Sarikaya B, Ceruso M, Carta F, Supuran CT. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones. Bioorg Med Chem. 2014 Nov 1;22(21):5883-90. doi: 10.1016/j.bmc.2014.09.021. Epub 2014 Sep 21. PubMed PMID: 25267005. 5: Carta F, Scozzafava A, Supuran CT. Sulfonamides: a patent review (2008 - 2012). Expert Opin Ther Pat. 2012 Jul;22(7):747-58. doi: 10.1517/13543776.2012.698264. Epub 2012 Jun 15. Review. PubMed PMID: 22697257. 6: Winum JY, Innocenti A, Vullo D, Montero JL, Supuran CT. Carbonic anhydrase inhibitors; fluorinated phenyl sulfamates show strong inhibitory activity and selectivity for the inhibition of the tumor-associated isozymes IX and XII over the cytosolic ones I and II. Bioorg Med Chem Lett. 2009 Sep 1;19(17):5082-5. doi: 10.1016/j.bmcl.2009.07.056. Epub 2009 Jul 23. PubMed PMID: 19632111.